Finansų apotheca, MB - financials and debts

Company age: 4 y. 8 mo.

Update

Finansų apotheca - Company finances

EUR
2022
From: 2022-01-13
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 24,453 23,031 13,571 39,582
Profit before tax 26 -149 690 1,296
Net profit 26 -149 655 1,205
Equity 28 -120 570 1,828
Liabilities 558 190 8 761
Non-current assets 0 0 0 0
Current assets 586 70 578 2,589
Total assets 586 70 578 2,589
Taxes paid
STI taxes - 17 34 45
Financial indicators
Revenue change y/y - -5.8% -41.1% +191.7%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 4.4% -212.9% 113.3% 46.5%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 92.9% - 114.9% 65.9%
Profit margin Net profit margin. Shows the overall profitability of the company. 0.1% -0.6% 4.8% 3.0%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 0.1% -0.6% 5.1% 3.3%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 19.9 - 0.0 0.4
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - - - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Finansų apotheca - Social security debts

From To Debt, €
2023-04-12 2023-04-30 532.23

Finansų apotheca - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Finansu apotheca, MB (code 305979801) is a Lithuanian small partnership operating in activities of insurance agents and brokers. In 2025, the company generated revenue of €39.6K, up from €13.6K in 2024 and €23.0K in 2023, showing a clear recovery and strong latest-year growth. Net profit reached €1.2K in 2025, after €655 in 2024 and a small loss of €149 in 2023. The profit margin was 3.0% in 2025, compared with 4.8% in 2024 and -0.6% in 2023. The balance sheet also improved over the period: total assets increased to €2.6K in 2025 from €578 in 2024 and €70 in 2023, while equity rose to €1.8K from €570 and turned positive after being negative in 2023. Liabilities stood at €761 in 2025. Key ratios indicate efficient use of the asset base, with asset turnover at 15.29x and returns on equity and assets at strong levels in 2025.